The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study

MLA

Feiyu Chen, et al. “The Efficacy and Safety of Lenvatinib for Advanced Hepatocellular Carcinoma in China: A Retrospective, Real-World Study.” Journal of Clinical Oncology, vol. 39, May 2021, p. e16182. EBSCOhost, https://doi.org/10.1200/jco.2021.39.15_suppl.e16182.

APA

Feiyu Chen, Jia Fan, Zhou Jian, De-Zhen Guo, & Xin-Rong Yang. (2021). The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in China: A retrospective, real-world study. Journal of Clinical Oncology, 39, e16182. https://doi.org/10.1200/jco.2021.39.15_suppl.e16182

Chicago

Feiyu Chen, Jia Fan, Zhou Jian, De-Zhen Guo, and Xin-Rong Yang. 2021. “The Efficacy and Safety of Lenvatinib for Advanced Hepatocellular Carcinoma in China: A Retrospective, Real-World Study.” Journal of Clinical Oncology 39 (May): e16182. doi:10.1200/jco.2021.39.15_suppl.e16182.